Yakun Kang
Overview
Explore the profile of Yakun Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang Y, Meng Y, Jin J, Dai Y, Li F, Chen N, et al.
Transl Oncol
. 2025 Feb;
54:102330.
PMID: 39986190
Background: Breast cancer is one of the most prevalent malignant tumors in women. Mitochondria, essential for cellular function, have altered metabolic activity in cancer cells, influencing tumor regulation and clinical...
2.
Chen W, Kang Y, Sheng W, Huang Q, Cheng J, Pei S, et al.
Front Immunol
. 2024 Feb;
15:1331841.
PMID: 38370403
Background: Breast cancer (BRCA) is a common malignancy in women, and its resistance to immunotherapy is a major challenge. Abnormal expression of genes is important in the occurrence and development...
3.
Zhong H, Chang L, Pei S, Kang Y, Yang L, Wu Y, et al.
Aging (Albany NY)
. 2024 Feb;
16(4):3531-3553.
PMID: 38358910
Despite the advent of precision therapy for breast cancer (BRCA) treatment, some individuals are still unable to benefit from it and have poor survival prospects as a result of the...
4.
Pei S, Zhang P, Yang L, Kang Y, Chen H, Zhao S, et al.
Front Immunol
. 2023 Mar;
14:1116839.
PMID: 36860848
Background: Despite tremendous advances in cancer research, breast cancer (BC) remains a major health concern and is the most common cancer affecting women worldwide. Breast cancer is a highly heterogeneous...
5.
Pei S, Zhang P, Chen H, Zhao S, Dai Y, Yang L, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1135297.
PMID: 36843602
Background: Although breast cancer (BC) treatment has entered the era of precision therapy, the prognosis is good in the case of comprehensive multimodal treatment such as neoadjuvant, endocrine, and targeted...